Product
AEB071
1 clinical trial
1 indication
Indication
Uveal melanomaClinical trial
Phase Ib Trial of AEB071, a PKC Inhibitor, in Combination With BYL719, a PI3Kα Inhibitor, in Patients With Metastatic Uveal MelanomaStatus: Completed, Estimated PCD: 2017-10-18